ABBVIE PTE LTD

ABBVIE PTE LTD in Singapore functions as both a manufacturing facility (factory) and a commercial entity.

Company Introduction:

ABBVIE PTE LTD is the Singapore subsidiary of AbbVie Inc., a global biopharmaceutical company dedicated to the discovery, development, manufacturing, and sale of innovative medicines. In Singapore, AbbVie has established a significant presence, prominently featuring a state-of-the-art biologics manufacturing facility situated in Tuas Biomedical Park. This facility serves as a crucial production hub, manufacturing active pharmaceutical ingredients and finished drug products that are vital to AbbVie's global supply chain. Beyond its manufacturing capabilities, ABBVIE PTE LTD also oversees commercial operations, which include the sales, marketing, and distribution of AbbVie's pharmaceutical products throughout the region. The company is committed to scientific innovation, improving patient lives, and contributing to Singapore's vibrant biomedical ecosystem through its research, development, and high-tech manufacturing activities.

ABBVIE PTE LTD in Singapore sells a wide range of pharmaceutical products across various therapeutic areas. These include medicines for immunology, oncology, neuroscience, virology, and women's health. Some prominent products sold include:

Immunology: Humira, Skyrizi, Rinvoq

Oncology: Venclexta (also known as Venclyxto in some regions), Imbruvica

Neuroscience and Aesthetics: Botox (for both therapeutic and cosmetic uses)

Virology: Mavyret

Women's Health: Oriahnn (also known as Orilissa in some regions)

Additionally, ABBVIE PTE LTD operates a significant manufacturing facility in Singapore. This facility produces Active Pharmaceutical Ingredients (APIs) and finished drug products that are integral to AbbVie's global supply chain. These manufactured components and products support the worldwide availability of many of AbbVie's key medicines, particularly complex biologic and small molecule therapies.